- Location
peripheral arterial disease
"-
Japanese Approval for Gliderxtreme Pta Catheter Han Been Obtained by Century Medical
Nov 22, 2013Century Medical, the Japanese partner of TriReme Medical, has obtained Shonin approval for the GliderXtreme PTA catheter, which is designed for the treatment of peripheral arterial blockages. GliderXtreme has a low-profile nitinol shaft ...
Tags: Century Medical, PTA Catheter
-
Gore Has Obtained an Approval From FDA for Its 25cm Gore Viabahn Endoprosthesis
Nov 11, 2013W. L. Gore & Associates (Gore) has obtained an approval from the US Food and Drug Administration (FDA) for its 25cm GORE VIABAHN endoprosthesis with heparin bioactive surface. The 25cm Gore Viabahn endoprosthesis is intended to treat ...
Tags: disease heal, health, cure, fda
-
ArjoHuntleigh Has Introduced The Dopplex Ability,ABI Screening Device.
Oct 18, 2013Global medical technology company ArjoHuntleigh has introduced the Dopplex Ability, an ankle brachial index (ABI) screening device. ABI measurements are used to predict the severity of peripheral arterial disease (PAD). The Dopplex ...
-
Cook Medical Has Announced That Effective October 1, 2013
Aug 30, 2013Cook Medical has announced that effective October 1, 2013, its Zilver PTX drug-eluting peripheral stent qualifies for new-technology add-on payments under Medicare’s hospital inpatient prospective payment system. In order to qualify ...
Tags: Cook Medical, clinical improvement
-
Enrolling Patients in Iliac Stent Clinical Studies Is Completed by Covidien
Feb 25, 2013Covidien has completed patient enrollment in its VISIBILITY and DURABILITY Iliac stent clinical study series. The prospective, multinational, multicenter studies, which have enrolled 150 patients from 23 centers in the US and Europe, are ...
-
Covidien Has Singed an Agreement to Acquire CV Ingenuity for Undisclosed Sum
Dec 28, 2012Global healthcare products provider Covidien has singed an agreement to acquire CV Ingenuity for undisclosed sum. The transaction is also expected to increase Covidien's research and development expenditures to fund the clinical ...
Tags: Global healthcare, Covidien, CV Ingenuity, DCB technology
-
First US Patient Is Riverside Methodist Treated with Cook's Zilver Ptx Stent
Dec 21, 2012US-based Riverside Methodist Hospital has implanted the first US patient with Cook Medical's Zilver PTX drug-eluting peripheral stent, designed for use in above-the-knee femoropopliteal artery. The stent, which is coated with paclitaxel ...
Tags: Methodist Hospital, Cook's Zilver PTX Stent, Medicak Device
-
Austin Heart Has Started Enrolling PAD Patients for Avinger's Connect II Trial
Dec 18, 2012Austin Heart, a provider of cardiac and vascular services, has started enrolling peripheral arterial disease (PAD) patients for Avinger's Connect II trial. The multi-center, non-randomized and prospective trial is designed to evaluate ...
Tags: Austin Heart, PAD patients, Connect II trial, peripheral arterial disease
-
Cook Medical Receives The Approval From FDA for Zilver PTX Drug-Eluting Peripheral Stent
Dec 18, 2012Cook Medical has received the regulatory approval from the US Food and Drug Administration (FDA) for its Zilver PTX drug-eluting peripheral stent, designed for treating peripheral arterial disease (PAD) in the superficial femoral artery. ...
Tags: Cook Medical, FDA, peripheral arterial disease, clinical product
-
C.R. Bard's Lutonix Technology Center Completes Enrolling Patients in IDE LEVANT 2 Trial
Dec 17, 2012C. R. Bard's Lutonix technology center has completed enrolling patients in its pivotal investigational device exemption (IDE) LEVANT 2 trial, designed to evaluate Lutonix drug coated PTA dilatation catheter (DCB) as a treatment for ...
Tags: pivotal investigational device, drug coated PTA dilatation catheter
-
FDA Has Approved Mylan Pharmaceuticals' Abbreviated New Drug Application
Nov 28, 2012The FDA has approved Mylan Pharmaceuticals' abbreviated new drug application (ANDA) for Clopidogrel tablets USP, 75mg and 300mg. The generic version of Sanofi-Aventis' Plavix is indicated for acute coronary syndrome and for patients with ...
Tags: Clopidogrel Tablets, Mylan Pharmaceuticals, drug application
